摘要
目的探讨17-β雌二醇对肾间质纤维化防治作用可能的机制。方法雌性SD大鼠30只,随机分为4组:①对照组;②生理雌激素组;③低雌激素组;④17-β雌二醇组。21d后光镜观察单侧梗阻肾组织病理改变;通过免疫组化方法检测转化生长因子(TGF-β1)、α-平滑肌动蛋白(α-SMA);并用RT-PCR方法检测肾组织α-SMAmRNA的表达。结果单侧输尿管梗阻各组出现肾小管间质纤维化改变,其肾组织TGF-β1。和α-SMA表达上调(P〈0.01);与生理雌激素组相比,低雌激素组纤维化病变加重,上述物质表达均明显增多(P〈0.05);而17-β雌二醇组则病变均减轻(P〈0.05)。结论注射17-β雌二醇可能通过下调TGF-β1,和α-SMA的表达,抑制细胞外基质的生成,进而韶到延绣肾间后纤维化的作用.
Objective To evaluate the effect of 17β-esfradiol on renal interstitial fibrosis and to explore the possible mechanism. Method Thirty Sprague-Dawley female rats were randomly divided into four groups, control group; normal estrogen group ( rats only underwent UUO) ; low estrogen group (rats were ovariectomized and underwent UUO); high estrogen group (rats underwent UUO and received 17β-estradiol injection). The rats were sacrificed after 21 days, renal tissues were examined by using PAS and Masson stains. Immunohistochemistry was used to determine the protein expressions of TGF-β1 and α-SMA, the mRNA expressions of α-SMA were detected with reverse transcription-polymerase chain reaction. Results Compared with control group, there appeared tubulointerstitial fibrosis developed in UUO groups, the expression of TGF-β1 and α-SMA increased remarkably (P〈0. 01). Compared with UUO group, the lesion was aggravated significantly in UUO + OVX group, with enhanced expression of TGF-β1 andαSMA enhanced (P〈0. 05), and in UUO + E2 group the lesion was attenuated,and the expression of those parameters decreased (P〈0. 05). Conclusions 17β- esfradiol may prevent the development of interstitial fibrosis by inhibiting the over expression of TGF- β1 and αSMA, which may consequently result in the production of extracellular matrix deposition.
出处
《临床肾脏病杂志》
2006年第3期99-101,i0001,共4页
Journal Of Clinical Nephrology